Zydus gets USFDA final approval for generic Dapagliflozin with 180-day shared exclusivity
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
Immediate opportunity in the $10.2 billion U.S. market as the diabetes therapy will be manufactured at Zydus’ SEZ Ahmedabad facility
MoU to deploy Qure.ai’s chest X-ray solution across 20 government facilities aims to improve early detection in urban and rural populations
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Board approves five-year appointment, subject to shareholder nod through postal ballot
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
The radiotherapy systems include TrueBeam, TrueBeam STx, VitalBeam, and Edge
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
Subscribe To Our Newsletter & Stay Updated